SCHEMBL30489214

SCHEMBL30489214

C=C1C[C@@H](C(F)(F)F)N(C(=O)OC(C)(C)C)C1=O

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ CHRM3 P20309 1/20 0.34
▸ KLK7 P49862 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ SCN9A Q15858 1/20 0.32
▸ RORC P51449 1/20 0.32
▸ NR1H2 P55055 1/20 0.32
▸ HPGD P15428 1/20 0.31
▸ KLK5 Q9Y337 1/20 0.31
▸ ELANE P08246 1/20 0.31
▸ GPR119 Q8TDV5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25650062 1.00 CHRM2 (0.34) CHRM2CHRM1CHRM3KLK7KDM4E
SCHEMBL20788494 0.78 KLK7 (0.36) CHRM2CHRM1CHRM3KLK7KDM4E
SCHEMBL5792537 0.78 KLK7 (0.36) CHRM2CHRM1CHRM3KLK7KDM4E
SCHEMBL25650061 0.77 DDB1 (0.32) CHRM2CHRM1CHRM3KLK7
SCHEMBL25650019 0.77 DDB1 (0.32) CHRM2CHRM1CHRM3KLK7
SCHEMBL24020702 0.76 PTPN1 (0.37) CHRM2CHRM1CHRM3KLK7KDM4E
SCHEMBL28926781 0.76 PTPN1 (0.37) CHRM2CHRM1CHRM3KLK7KDM4E
SCHEMBL17113461 0.75 CHRM2 (0.41) CHRM2CHRM1CHRM3KDM4EMAPT
SCHEMBL31133635 0.75 CHRM2 (0.41) CHRM2CHRM1CHRM3KDM4EMAPT
SCHEMBL25650059 0.75 CHRM2 (0.41) CHRM2CHRM1CHRM3KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688156-A1 LACTAM-CONTAINING IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS Janssen Pharmaceutica NV (BE) 2026-02-11 — — EP disclosed
WO-2024201322-A1 LACTAM-CONTAINING IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2024-10-03 — — WO disclosed
WO-2023111181-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-06-22 — — WO disclosed
Send feedback